SCHEMBL5752124

SCHEMBL5752124

CC(C)(C)c1ccc(CC(NC(=O)c2cccc3c(F)cccc23)C(O)c2cccc(Cl)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 4/20 0.38
BCHE P06276 3/20 0.38
NR1H4 Q96RI1 2/20 0.37
EPHX2 P34913 1/20 0.37
CTSV O60911 1/20 0.36
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
CTSS P25774 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
ADRB1 P08588 3/20 0.35
ADRB3 P13945 3/20 0.35
MCHR1 Q99705 1/20 0.35
FFAR2 O15552 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5751559 0.96 BACE1 (0.40) BACE1BCHENR1H4EPHX2CTSV
SCHEMBL1897805 0.91 BACE1 (0.39) BACE1BCHENR1H4CTSVCTSL
SCHEMBL5754553 0.89 ADRB3 (0.39) CTSVCTSLCTSBCTSSADRB1
SCHEMBL5752908 0.89 MCHR1 (0.37) BACE1CTSVCTSLCTSBCTSS
SCHEMBL5752893 0.88 BACE1 (0.42) BACE1BCHECTSVCTSLCTSB
SCHEMBL5749506 0.87 ADRB3 (0.37) BACE1BCHECTSVCTSLCTSB
SCHEMBL5751172 0.87 BACE1 (0.38) BACE1BCHENR1H4EPHX2KMT2A
SCHEMBL5752643 0.85 CNR1 (0.42) CYP1A2CYP2C19ADRB1ADRB3CNR1
SCHEMBL5752027 0.84 FFAR2 (0.37) CTSVCTSLCTSBCTSSCYP1A2
SCHEMBL5754506 0.83 ADRB3 (0.37) BACE1CTSVCTSLCTSBCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP BACE1 835/4885BCHE 334/4885NR1H4 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.